Auditor region Client organizations
By number of organizations
| ALN | Program | Audits |
|---|---|---|
| 93.395 | Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin [phase Ii] | 1 |
| 93.866 | A Liposomal Platform for Spontaneous, Particleized Presentation of Hiv Trimer Immunogen | 1 |
| 93.855 | Developing A Thermostable Sars-Cov-2 Rbd-Particle Vaccine | 1 |
Breakdown of auditee types
| ID | Year | Date Accepted | Organization | State | Spend |
|---|---|---|---|---|---|
| 343831 F | 2023 | 2025-02-26 | Pop Biotechnologies Inc. | NY | $1.90M |